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Lipids modulate the function of many ion channels, possibly through direct lipid-protein
interactions. The recent outpouring of ion channel structures by cryo-EM has revealed
many lipid binding sites. Whether these sites mediate lipid modulation of ion channel
function is not firmly established in most cases. However, it is intriguing that many of these
lipid binding sites are also known sites for other allosteric modulators or drugs, supporting
the notion that lipids act as endogenous allosteric modulators through these sites. Here,
we review such lipid-drug binding sites, focusing on pentameric ligand-gated ion channels
and transient receptor potential channels. Notable examples include sites for phospholipids
and sterols that are shared by anesthetics and vanilloids. We discuss some implications
of lipid binding at these sites including the possibility that lipids can alter drug potency or
that understanding protein-lipid interactions can guide drug design. Structures are only
the first step toward understanding the mechanism of lipid modulation at these sites.
Looking forward, we identify knowledge gaps in the field and approaches to address
them. These include defining the effects of lipids on channel function in reconstituted
systems using asymmetric membranes and measuring lipid binding affinities at specific
sites using native mass spectrometry, fluorescence binding assays, and computational
approaches.
Keywords: lipid binding sites, pentameric ligand-gated ion channel, transient receptor potential channel, allosteric
modulation, cryo-EM, photoaffinity labeling, native mass spectrometry, molecular dynamics simulations

INTRODUCTION
Lipids regulate the structure and function of ion channels, which are embedded in complex and
dynamic lipid membrane environments. Classic examples include cholesterol activation of the
nicotinic acetylcholine receptor (nAchR; Ochoa et al., 1983; Criado et al., 1984) and phosphatidylinositol
activation of inward rectifying potassium (Kir) channels (Hilgemann and Ball, 1996; Shyng and
Nichols, 1998). It is now known that all types of ion channels, from voltage-gated and transient
receptor potential (TRP) channels to mechanosensitive channels, are regulated by lipids (RosenhouseDantsker et al., 2012; Thompson and Baenziger, 2020). While the physiologic and pathophysiologic
implications of these effects are not known in most cases, pharmacologically targeting mechanisms
of lipid regulation, such as lipid binding sites, may provide a useful approach to treat channelopathies
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or other diseases (Reddy and Estes, 2016; Arul Prakash and
Kamlekar, 2021; Payandeh and Volgraf, 2021).
Lipids may regulate ion channels by direct binding to
specific sites or indirect effects on membrane physical
properties (Cordero-Morales and Vasquez, 2018). The recent
outpouring of ion channel structures by cryo-electron
microscopy (cryo-EM) has revealed many structures with
bound lipids. While these structures have provided striking
insight into lipid-channel interactions, in few cases is it
known whether lipid occupancy of these sites is functionally
important. Interestingly, some of these sites are also known
sites of action for other allosteric modulators or drugs,
supporting the hypothesis that lipids modulate channel
function by binding to these sites. For example, lipid densities
have been observed in anesthetic binding sites in pentameric
ligand-gated ion channels (pLGICs) and in the vanilloid
binding site in transient receptor potential (TRP) channels.
Here, we will review such lipid-drug binding sites from
recent structural studies with a focus on pLGICs and TRP
channels. We discuss potential implications of these shared
lipid-drug sites for understanding drug action and structurebased drug design. As the structural data raise questions
regarding the selectivity and functional significance of lipid
binding to these sites, we highlight several approaches to
address these questions in future research efforts.

McNamee, 1986; Hamouda et al., 2006). These lipid constituents
specifically interact with the transmembrane domain (TMD)
at putative annular and non-annular sites (Marsh and Barrantes,
1978; Marsh et al., 1981; Gonzalez-Ros et al., 1982; Jones
and McNamee, 1988). The GABAAR is also modulated by
cholesterol (Sooksawate and Simmonds, 2001a), certain
phospholipids, such as phosphatidylserine (Hammond and
Martin, 1987; Dostalova et al., 2010, 2014), as well as
polyunsaturated fatty acids (Hamano et al., 1996; Nabekura
et al., 1998), and neurosteroids (Belelli and Lambert, 2005).
In contrast, the lipid sensitivities of other pLGICs, such as
the serotonin receptor (5-HT3aR; Fan, 1995; Nothdurfter et al.,
2013), glycine receptor (GlyR; Yang et al., 2008), and
non-mammalian pLGICs (e.g., ELIC: Tong et al., 2019 and
GLIC: Velisetty and Chakrapani, 2012) are less wellcharacterized. Nevertheless, pLGICs are undoubtedly lipidsensitive channels. There now exists a large inventory of highresolution structures encompassing all types of pLGICs, many
of which show lipid-drug binding sites. Such sites provide a
structural framework to begin clarifying mechanisms of lipid
modulation in this family of ion channels.
pLGICs consist of homo- or hetero-pentamers with four
transmembrane helices per subunit. Orthogonal to the
membrane, these helices are approximately organized as three
rings, from the pore to the surrounding lipid membrane. The
inner ring consists of transmembrane helix 2 (M2), which
lines the channel pore, the intermediate ring consists of M1
and M3, and the outer ring consists of M4, which has the
greatest exposure to lipids (Barrantes and Fantini, 2016;
Figure 1A). Between these helices are grooves that are generally
conserved among all pLGICs; M1 and M3 form an intersubunit
groove, while M1 and M4 or M3 and M4 form intrasubunit
grooves. These grooves are known binding sites for many
allosteric modulators. In this review, we organize these sites
as intersubunit and intrasubunit sites in the outer or inner
leaflet (Figure 1B). This delineation (i.e., outer versus inner)
is useful for discussion of these sites, although it may be an
oversimplification for some deeply bound lipids, which may

LIPID-DRUG BINDING SITES IN pLGICs
pLGICs, such as the nicotinic acetylcholine receptor (nAchR)
and GABA(A) receptor (GABAAR), mediate synaptic
neurotransmission and determine neuronal excitability. Over
four decades ago, the nAchR from Torpedo muscle was the
first ion channel found to be sensitive to its lipid environment.
The nAchR requires cholesterol, phosphatidylethanolamine
(PE), and anionic phospholipids, such as phosphatidylserine
(PS), for maximal channel responses to agonist (Dalziel et al.,
1980; Criado et al., 1982, 1984; Ochoa et al., 1983; Fong and

A

B

FIGURE 1 | TMD lipid-drug binding sites in pLGICs illustrated using the GLIC structure (pdb 4hfi). (A) Top/extracellular view of the TMD helices showing the 3-ring
organization. (B) Two adjacent TMD subunits illustrating the general location of inter- and intrasubunit sites in the outer and inner leaflet.
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FIGURE 2 | Outer leaflet intersubunit binding site in pLGICs. (A) α1/β2 interface of α1/β2/γ2 GABAAR with GABA and propofol (pdb 6x3t), and the α1/β2 interface
of α1/β2/γ2 GABAAR with the competitive antagonist, bicuculline (pdb 6x3s). The activated conformation in the GABA + propofol structure is associated with an
outward movement (away from the pore axis) of the top of M2, M3 and the M2-M3 linker. (B) GluCl with POPC (pdb 4tnw) and GluCl with ivermectin (pdb 3rhw).
Binding of ivermectin to the intersubunit site opens the channel pore and is associated with similar conformational changes as noted above in the GABAAR. (C) Apo
ELIC with cardiolipin (pdb 7l6q). The cardiolipin occupies a surface at the intersubunit site.

Outer Leaflet Intersubunit Site

not clearly associate with lipids from one membrane leaflet.
In addition, most pLGICs including the GABAAR and nAchR
assemble as heteropentamers, increasing the number of unique
sites within the pentameric assembly. For example, the most
prevalent composition of synaptic GABAAR consists of two
α1 subunits, two β2 or β3 subunits and one γ2 subunit with
an arrangement of α1-β2-α1-β2-γ2. Thus, there are three
distinct subunits and four distinct interfaces in the
heteropentameric GABAAR.
Frontiers in Physiology | www.frontiersin.org

Perhaps the best characterized site for allosteric modulators
in the TMD of pLGICs is an outer leaflet intersubunit site.
Photolabeling studies and cryo-EM structures have definitively
established this to be the binding site for the intravenous
general anesthetics, etomidate, propofol, and pentobarbital, in
heteromeric GABAARs (Li et al., 2006, 2010; Chiara et al.,
2012, 2013; Jayakar et al., 2014; Kim et al., 2020) and nAchRs
(Nirthanan et al., 2008; Hamouda et al., 2011; Jayakar et al.,
3

January 2022 | Volume 12 | Article 798102

Cheng et al.

Lipid Binding Sites

2013; Figure 2A) with each drug showing specificity for certain
interfaces. This site is also occupied by the positive allosteric
modulator, ivermectin, in GluCl from c. elegans (Hibbs and
Gouaux, 2011) and the α1 homopentameric GlyR (Kumar et al.,
2020). The outer leaflet intersubunit site is located between
M1 and M3 of neighboring subunits. The upper border of
this site is formed by the M2-M3 loop, and more deeply bound
ligands contact M2 (Figure 2A). In all pLGIC structures for
which there are apo and agonist-bound states, this site undergoes
major conformational changes with displacement and overall
expansion of M1 and M3, and an associated outward shift of
the M2-M3 linker that leads to opening of the pore-lining
M2 (Basak et al., 2018a,b; Kumar et al., 2020; Noviello et al.,
2021; Zhang et al., 2021b; Figure 2A). Thus, there is evidence
to indicate that this outer leaflet intersubunit site is a conserved
allosteric hotspot in pLGICs (Reynolds et al., 2011).
The first structure showing a phospholipid bound to this
site is that of GluCl crystallized in the presence of POPC
(palmitoyl-oleoyl phosphatidylcholine); a POPC density was
identified in this site (i.e., the ivermectin binding site), which
produced a significant shift of the TMD helices relative to a
structure without POPC (Althoff et al., 2014). Compared to
the ivermectin-bound structure of GluCl, which shows an open
pore, the POPC-bound structure is non-conducting. Binding
of the bulky ivermectin molecule to the intersubunit site leads
to enlargement of this binding pocket, displacement of M3
and outward movement of the M2-M3 linker and M2: key
conformational changes associated with opening of the channel
pore (Figure 2B). Interestingly, POPS (palmitoyl-oleoyl
phosphatidylserine) competes for ivermectin binding and
potentiates agonist (glutamate) binding unlike POPC, suggesting
that PS may positively modulate GluCl channel activity through
this site. Unfortunately, structures of GluCl in the presence
of POPS could not be obtained, and the modulatory effect of
POPS on GluCl channel function is not known (Althoff et al.,
2014). Nevertheless, the POPC-bound GluCl structure reveals
how lipid binding to the outer leaflet intersubunit site may
alter the conformation and activation state of a pLGIC.
Recent pLGIC structures determined by cryo-EM have also
demonstrated lipid densities in this outer leaflet intersubunit
site. Structures of the α1β2γ2 GABAAR in complex with the
general anesthetics, propofol, and diazepam, show putative
lipid densities in this site at each interface of this heteromeric
channel (Kim et al., 2020). The structures were obtained from
GABAARs in saposin-based nanodiscs with porcine brain polar
lipids. The lipid densities vary in appearance at different
subunit interfaces and are partially displaced or absent when
the intersubunit sites are occupied by propofol (α1/β2) or
diazepam (β2/α1 and γ2/β2). Interestingly, a phospholipid
density is also observed at the α1/γ2 interface, which has
been called an orphan site as no anesthetic is known to bind
to this site (Nourmahnad et al., 2016). Structures of the
homomeric 5-HT3aR in saposin-based nanodiscs with porcine
brain lipids also show phospholipid-like densities in the outer
leaflet intersubunit site (Zhang et al., 2021b). These densities
are stronger in the agonist-bound structure compared to the
apo structure and associated with significant expansion of
Frontiers in Physiology | www.frontiersin.org

the intersubunit pocket, suggestive that the phospholipid
preferentially binds to the agonist-bound conformation of the
channel. The bound phospholipid is buried between M1 and
M3, making multiple hydrophobic interactions with these
helices and the M2-M3 linker. Lastly, a recent apo structure
of the prokaryotic pLGIC, ELIC, in SMA nanodiscs from
Escherichia coli membranes shows cardiolipin bound to this
site (Kumar et al., 2021; Figure 2C). The large cardiolipin
molecule interacts with a region of the TMD that encompasses
the outer leaflet intersubunit site, although the lipid is binding
more to the surface of this site than in the aforementioned
structures (Figure 2C). The observation of bound cardiolipin
provides a glimpse into lipid interactions with ELIC in a
membrane similar to its native lipid environment. However,
only an apo structure was reported in this study limiting
our understanding of lipid modulation, as cardiolipin increases
the open probability of ELIC in the presence of agonist (Kumar
et al., 2021). Whether cardiolipin or other phospholipids
modulate ELIC channel activity through this site is not clear.
The outer leaflet intersubunit site has also been the subject
of study using molecular dynamics (MD) simulations. Coarsegrained MD simulations of the GlyR in a neuronal-like membrane
show increased binding of cholesterol at this site in the agonistbound conformation compared to apo (Damgen and Biggin,
2021). The steroid intercalates between an enlarged space between
M1 and M3 in the agonist-bound state, similar to results from
MD simulations of the GABAAR that predict cholesterol binding
in this site (Henin et al., 2014). The simulations also suggest
that phospholipids interact differentially at this site; phospholipids
form more stable interactions with pre-M1 in the agonistbound state (Damgen and Biggin, 2021). Similarly, coarse-grained
MD simulations of the muscle-type αβγδ nAchR in neuronallike membranes show that cholesterol binds to the outer leaflet
intersubunit site with the highest affinity, while n-3
polyunsaturated phospholipids also occupy this site with lower
affinity (Sharp and Brannigan, 2021). Consistent with these
computational studies, a crystal structure of a GLIC-α1GABAAR
chimera shows densities of the cholesterol analogue, cholesteryl
hemisuccinate, at approximately this site (Laverty et al., 2017).
In summary, the outer leaflet intersubunit site in pLGICs
is a key binding site for allosteric modulators. Structural and
computational studies indicate that phospholipids and steroids
bind to this site, with certain lipids possibly favoring agonistbound, activated conformations.

Inner Leaflet Intersubunit Site

In pLGICs, the inner leaflet of the intersubunit groove also
forms a hydrophobic pocket for allosteric modulators, especially
neurosteroids. 3α-hydroxy-pregnane neurosteroids such as
THDOC and the neurosteroid-analog anesthetic, alphaxalone,
potentiate the GABAAR by binding to this site at the α1/β3
interface (Laverty et al., 2017; Miller et al., 2017; Chen et al.,
2018, 2019; Sugasawa et al., 2019, 2020; Jayakar et al., 2020).
The site is formed by residues that are generally conserved
in pLGICs, including W245 and Q241 (this glutamine is
conserved among α isoforms; Hosie et al., 2009) in M1 of
α1, and L297, F301 and Y304 in M3 of β3. A hydrogen bond
4
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interaction between α1 Q241 and the neurosteroid 3-hydroxyl,
and a ring stacking interaction between α1 W245 and the
steroid backbone are critical for neurosteroid binding orientation
and effect (Chen et al., 2019; Sugasawa et al., 2019; Figure 3A).
Still, the exact mechanism by which neurosteroids modulate
GABAAR gating is unclear as structures with and without
bound neurosteroid show minimal changes in protein
conformation, and in all structures the pore is in a putative
desensitized conformation (Laverty et al., 2017; Miller et al.,
2017; Chen et al., 2018). The inner leaflet intersubunit site is
also thought to mediate volatile anesthetic modulation of pLGICs
(Spurny et al., 2013).
In addition to being a critical site of action for anesthetics,
such as alphaxalone, the inner leaflet intersubunit site is also
a binding site for cholesterol and phospholipids. Photolabeling
and docking studies show that cholesterol binds to this site
in GLIC (Budelier et al., 2019) and the GABAAR (Lee, 2021),
competing with neurosteroids. Moreover, cryo-EM structures
of the GABAAR (Zhu et al., 2018) and nAchR (Walsh et al.,
2018) show putative CHS densities in approximately the same
site. In a crystal structure of ELIC in the apo/resting state, a

phospholipid is also bound to this site (Henault et al., 2019;
Figure 3B). The identity of this co-purified phospholipid is
not established and may be PE (Henault et al., 2019) or PG
(Tong et al., 2019; Sridhar et al., 2021). Interestingly, PG
stabilizes the open state of ELIC relative to the desensitized
state (Tong et al., 2019), and desensitization in ELIC is associated
with a conformational change of M4 that may occlude this
phospholipid binding site, providing a plausible mechanism
for PG modulation of the open-desensitized equilibrium in
ELIC (Henault et al., 2019). However, without an open structure
of ELIC complexed to phospholipid, such a mechanism remains
uncertain. Thus, the inner leaflet intersubunit site is an established
binding site for allosteric modulators such as neurosteroids
and may also be a site through which cholesterol or phospholipids
modulate pLGIC gating.

Intrasubunit Sites

Intrasubunit pockets between M1/M4 and M3/M4, particularly
in the outer leaflet, are also binding sites for allosteric modulators
and lipids. Propofol and the volatile anesthetic, desflurane, bind
to an intrasubunit site in GLIC located within the four-

A

B

FIGURE 3 | Inner leaflet intersubunit binding site in pLGICs. (A) GLIC-α1GABAAR chimera at pH 4.5 with THDOC (pdb 5osb). Q264 forms a hydrogen bond
interaction with the 3-hydroxyl group of the neurosteroid, and W245 forms a hydrophobic ring stacking interaction with the steroid backbone. (B) Apo ELIC with
phosphatidylethanolamine (pdb 6hjx). Shown is W224, which is a highly conserved tryptophan in pLGICs that interacts with neurosteroids (A) and forms this lipid
binding site.

Frontiers in Physiology | www.frontiersin.org
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in Torpedo membranes showed low-density patches corresponding
to cholesterol at outer leaflet M1/M4 intrasubunit sites,
particularly in the δ subunit (Unwin, 2017, 2020). Cholesterol
occupancy of these sites is thought to underlie the requirement
of this steroid for nAchR gating efficacy.
Recent structures have also implicated an inner leaflet
intrasubunit site between M3 and M4 as a lipid binding site,
although there is little evidence to show that other allosteric
modulators or drugs act at this site (Figure 1). The crystal
structure of a GLIC-α1GABAAR chimera in complex with
pregnenolone sulfate (PS) shows a density at this site consistent
with PS (Laverty et al., 2017; Figure 5A). There is, however,
some controversy whether PS inhibition of the GABAAR is
mediated by this inner leaflet site, since this anionic neurosteroid
is a rapid and effective inhibitor when applied extracellularly
(Germann et al., 2019). This site may also be a cholesterol
binding site based on a recent photolabeling study (Krishnan
et al., 2021). Cryo-EM structures of the GABAAR and GlyR
also show phospholipid densities in this site. In α1β3γ2 GABAAR
structures from receptors in brain lipid nanodiscs, a density
consistent with PIP2 is present solely in the α1 subunit at this
intrasubunit site (Laverty et al., 2019; Figure 5B). The PIP2
density is present in the apo structure and structures complexed
with biccuculine or GABA/alphaxalone, showing no obvious
dependence on channel conformational. Moreover, GABAAR
gating is not significantly impacted by PIP2; thus, the functional
significance of this PIP2 binding site remains unknown. In
GlyR structures from receptors in asolectin lipid nanodiscs, a
phospholipid-like density is also apparent at this site in only
the apo structure (Kumar et al., 2020).
In summary, outer leaflet intrasubunit sites in pLGICs are
sites of action for anesthetics and other allosteric modulators,
and phospholipids and cholesterol likely exert significant
modulatory effects by binding to these sites. In contrast, the
inner leaflet M3/M4 intrasubunit site is a recently established
binding site for PIP2 and possibly other lipids; the functional
significance of this site is unclear and may involve effects on
ion channel trafficking instead of gating (Laverty et al., 2019).

transmembrane helix bundle; binding to this site is
thought to mediate a potentiating effect (Nury et al., 2011;
Arcario et al., 2017; Fourati et al., 2018; Figure 4A). MD
simulations indicate that propofol and desflurane enter this
site through a membrane-embedded pathway between M1 and
M4 (Arcario et al., 2017). Propofol also binds to this intrasubunit
pocket in ELIC (Kinde et al., 2016), the δ subunit of the
Torpedo nAchR (Jayakar et al., 2013), and the β3 subunit of
the GABAAR (Yip et al., 2013) based on photolabeling studies.
The binding affinity of propofol is >20x higher for the agonistbound/desensitized state compared to the apo state in the
nAchR δ intrasubunit site, supporting the idea that propofol
stabilizes the desensitized state of the nAchR through this site
(Arevalo et al., 2005; Jayakar et al., 2013). 3α-pregnane
neurosteroids such as allopregnanolone also bind to outer leaflet
M3/M4 and M1/M4 intrasubunit sites in the GABAAR leading
to distinct modulatory effects; allopregnanolone potentiates the
GABAAR through an α1 M1/M4 intrasubunit site and inhibits
through a β3 M3/M4 intrasubunit site (Sugasawa et al., 2020).
Unlike propofol, these sites are located along the TMD-lipid
surface within intrasubunit grooves. Similarly, the 5-HT3aR
positive allosteric modulator, TMPPAA, may also bind to the
M1/M4 intrasubunit groove (Polovinkin et al., 2018).
Structural studies have identified phospholipids, fatty acids,
and cholesterol bound to these outer leaflet intrasubunit grooves
in sites overlapping with that of allosteric modulators. One
notable example is structures of GLIC where a phospholipid
density occupies the outer leaflet M1/M3 intrasubunit site and
is displaced when propofol is bound (Bocquet et al., 2009;
Nury et al., 2011; Figure 4A). Interestingly, this lipid density
is present in the GLIC open structure, but absent in locallyclosed structures in which a shift in the top of M2, M3, and
M4 reduces the volume of this intrasubunit site (Prevost et al.,
2012; Figure 4A). This result suggests that phospholipid
occupancy of this site stabilizes the open state of GLIC. On
the other side of M4, the outer leaflet M3/M4 intrasubunit
site is a binding site for the polyunsaturated fatty acid,
docosahexaenoic acid (DHA), in GLIC (Basak et al., 2017;
Dietzen et al., 2021; Figure 4B). The carboxylate group of
DHA is adjacent to R318 forming an ionic interaction with
this residue; however, it is less clear how the polyunsaturated
tail interacts with the channel as this was not fully resolved
in the structure (Figure 4B). The DHA binding site in GLIC
is similar to the inhibitory neurosteroid binding site in the
GABAAR (Sugasawa et al., 2020). Thus, the M3/M4 intrasubunit
site may be a common binding site for DHA and neurosteroids
that mediate inhibition of some pLGICs. Cholesterol binding
to outer leaflet intrasubunit sites was first proposed based on
cryo-EM structures of the Torpedo nAchR from native membranes
in which large gaps between protein densities suggested the
presence of lipids (Toyoshima and Unwin, 1988; Unwin, 1995,
2005; Miyazawa et al., 2003). Subsequent docking and MD
simulations revealed that these sites are occupied by multiple
cholesterol molecules, which are necessary to maintain the
spaced-apart arrangement of transmembrane helices as well
as contacts between ECD and TMD loops (Brannigan et al.,
2008). Further refinements of the cryo-EM images of the nAchR
Frontiers in Physiology | www.frontiersin.org

LIPID-DRUG BINDING SITES IN TRP
CHANNELS
TRP channels are a superfamily of cation-selective channels
that are implicated in many physiologic functions including
temperature sensation and regulated by diverse stimuli including
lipids (Clapham et al., 2001). Various TRP channels are regulated
by PIP2 and other anionic phospholipids, cholesterol,
neurosteroids, fatty acids, endocannabinoids, and many lipid
metabolites produced with tissue inflammation (Wagner et al.,
2008; Sisignano et al., 2014; Rohacs, 2015; Taberner et al.,
2015; Morales-Lazaro and Rosenbaum, 2017). Most TRP channels
are regulated by PIP2 or other phosphoinositides, and the effects
of phosphoinositides on different TRP channels vary and are
quite complex. For example, both activating and inhibiting
effects have been described for PIP2 in TRPV1, TRPV4, and
TRPC channels, while only activating effects have been reported
6
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A

B

FIGURE 4 | Outer leaflet intrasubunit binding sites in pLGICs. (A) GLIC with phosphatidylcholine (pdb 3eam), GLIC with propofol (pdb 3p50), and the GLIC
loop 2–21′ oxidized mutant which is a locally-closed conformation (pdb 3tlw). The +phosphatidylcholine and + propofol structures are similar while the locally-closed
structure shows a tilting of the top of M2, M1 and M4 that reduces the size of the intrasubunit space between the helical bundles. (B) GLIC with docosahexaenoic
acid (DHA; pdb 5j0z), which is similar to the structure of GLIC without DHA (pdb 3eam). R118 in the β6-β7 loop likely forms an ionic interaction with the DHA
carboxylate group.

in other TRPV channels (e.g., TRPV5) and all TRPM channels
(Rohacs, 2015). The recent explosion of TRP channel structures
have revealed many lipid binding sites, some of which are
also sites for exogenous drugs/modulators or phosphoinositides.
We will review these structures with a focus on lipid-drug
sites and PIP2 binding sites. For a more comprehensive treatment
of ligand binding sites in TRP channels, the reader may refer
to a recent review on this topic (Zhao et al., 2021).
Frontiers in Physiology | www.frontiersin.org

The architecture of TRP channels consists of a tetramer
with six transmembrane helices (S1–S6). These helices comprise
the voltage-sensing like domain (VSLD, S1–S4) and pore domain
(S5–S6), connected by the critical S4–S5 linker. Also, lining
the inner membrane interface are the N-terminal pre-S1 domain
and the C-terminal TRP domain (Figure 6A). Amidst these
TMD elements are semi-conserved inner and outer leaflet
ligand-binding pockets that in many TRP channels are also
7
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A

B

FIGURE 5 | Inner leaflet M3/M4 intrasubunit binding site (A) GLIC-α1GABAAR with pregnenolone sulfate (pdb 5osc). (B) α1β3γ2 GABAAR with PIP2 bound to the
α1 subunit (pdb 6i53).

A

B

FIGURE 6 | TRP channel TMD architecture, and schematic of lipid-drug or lipid binding sites in TRP channels illustrated using the TRPV1 lipid nanodisc structure
(pdb 5irz). (A) Single subunit of TRPV1 labeling the helices and domains. The VSLD consists of S1-S4 helices. (B) Three subunits of the TRPV1 tetramer are shown
indicating the location of lipid-drug or lipid binding sites as described.

Frontiers in Physiology | www.frontiersin.org
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lipid binding sites. We will examine these lipid-drug binding
sites, which include the vanilloid-binding site (i.e., the binding
site for capsaicin in TRPV1) and the VSLD binding site, as
well as binding sites for PIP2 and other lipids (Figure 6B).

The vanilloid binding site is also the site of action of the
TRPV5 antagonist, econazole (Hughes et al., 2018a), and the
TRPA1 biased agonist, GNE551 (Liu et al., 2021; Figure 7B).
Moreover, mutations within this site in TRPV2 and TRPV3
render these channels sensitive to vanilloid agonists (Yang et al.,
2016; Zhang et al., 2019). Thus, this site is relatively conserved
among all TRP channels and is an allosteric hotspot, where
conformational changes of the S4-S5 linker and TRP domain
are linked to the pore-lining S6 (Zhao et al., 2021).
It is no surprise, then, that the vanilloid binding site is
often occupied by a lipid, especially in cryo-EM structures of
TRP channels in lipid nanodiscs. The most notable example
is a PI (phosphatidylinositol) phospholipid that was resolved
in the apo, closed structure of TRPV1 in asolectin nanodiscs
(Gao et al., 2016). Unlike the vanilloid agonist, RTX, the anionic
PI headgroup interacts with a slightly expanded binding pocket

Vanilloid Binding Site

The vanilloid binding site, which binds capsaicin (the active
component of chili peppers) in TRPV1, is an inner leaflet
pocket bound by S3/S4 of the VSLD, the S4-S5 linker, and
the pore-forming S6 of the adjacent subunit (in domain-swapped
TRP channels such as TRPV1; Cao et al., 2013; Gao et al.,
2016; Figures 6, 7). A structure of TRPV1 complexed with
the vanilloid agonist, resiniferatoxin (RTX), shows specific
interactions of RTX in this hydrophobic pocket that are associated
with outward displacement of the S4–S5 linker and S6, and
opening of a lower pore gate at S6 (Gao et al., 2016; Figure 7A).

A

B

FIGURE 7 | Vanilloid binding site in TRP channels. (A) TRPV1 with phosphatidylinositol (PI; pdb 5irz) and TRPV1 with resiniferatoxin (RTX; pdb 5irx). The headgroup
of PI is predicted to interact with R557, K571 and Q700. Replacement of PI in this pocket with RTX leads to outward movement of the S4-S5 linker, TRP domain
and S6 producing opening of the channel pore. (B) TRPA1 with phosphatidylcholine (pdb 6pqq) and TRPA1 with GNE551 (pdb 6x2j). E864 in the S4-S5 linker is
predicted to interact with the phospholipid headgroup. There is no difference in protein conformation between lipid-bound and agonist-bound structures.

Frontiers in Physiology | www.frontiersin.org

9

January 2022 | Volume 12 | Article 798102

Cheng et al.

Lipid Binding Sites

that includes polar/charged interactions with residues at the
pre-S1 region and TRP domain, in addition to the bottom of
S4 and the S4-S5 linker (Figure 7A). Specifically, the PI
headgroup interacts with R557 and K571 in the S4-S5 linker
(Figure 7A). When a vanilloid binds, this pocket re-arranges
such that R557 interacts with E570 within the S4-S5 linker
pulling the S4-S5 linker, S5 and S6 away from the central
axis and opening the channel pore (Figure 7A). A recent
cryo-EM study showing multiple snapshots of TRPV1
demonstrates stepwise displacement of the PI acyl chains by
RTX followed by the PI headgroup (Zhang et al., 2021a).
Visualization of these intermediates shows that PI lipids from
all four subunits must be displaced to produce conformational
changes in S5 and S6 associated with channel opening. The
striking overlap between PI and RTX in this site suggests the
possibility that PI is an antagonist of vanilloids in TRPV1.
Indeed, a recent study showed that PI inhibits TRPV1 in
excised inside-out patches, and that inhibition is the strongest
at low capsaicin concentrations and lost at high capsaicin
concentration, suggesting that PI competitively inhibits capsaicin
activation of TRPV1 (Yazici et al., 2021). A similar example
of overlapping lipid-drug binding modes was also observed
in TRPA1 structures in complex with the agonist, GNE551
(Suo et al., 2020; Liu et al., 2021; Figure 7B). A phospholipid
occupies this site (equivalent to the vanilloid binding site in
TRPV1) in the TRPA1 apo structure and is displaced when
GNE551 binds. The phospholipid headgroup is adjacent to
E864 in the S4-S5 linker (Figure 7B) and mutation of this
residue to a bulky tryptophan, which may occlude lipid binding
to this site, increases basal channel activity (Liu et al., 2021).
This result is consistent with lipid binding to this site antagonizing
channel activation. However, the apo and GNE551-bound
structures show a similar non-conducting conformation, and
so the mechanism of GNE551-mediated activation of TRPA1
is not entirely clear (Figure 7B). Also, it is not known whether
specific phospholipids bind to this site in TRPA1 or if lipids
antagonize GNE551-mediated TRPA1 activation.
A lipid occupies the equivalent vanilloid binding site in
many other TRP channel structures, some of which show
evidence of state-dependent lipid binding. Recent structures
of TRPV3 in NW11 asolectin nanodiscs at different temperatures
illuminate the mechanism of heat activation of TRPV3. The
closed structure shows a phospholipid in this site that is
excluded from this pocket by a conformational change in the
heat-activated open structure (Nadezhdin et al., 2021), similar
to the state-dependence of PI binding in TRPV1. MD simulations
suggest that this pocket is relatively non-selective for different
glycerophospholipids (PI, PC, PS, and PE), and is less favorable
for cholesterol (Nadezhdin et al., 2021). In contrast, structures
of TRPV6 and TRPV3 in MSP2N2 asolectin nanodiscs show
a phospholipid density in this site in activated conformations
with loss of the lipid in the closed conformations, suggesting
a mechanism whereby lipids may be agonists or positive allosteric
modulators of these channels (McGoldrick et al., 2018; Deng
et al., 2020). Structures of other TRP channels including TRPV2
(Zubcevic et al., 2016), TRPM2 (Zhang et al., 2018), TRPM4
(Autzen et al., 2018; Duan et al., 2018b), TRPC4 (Duan et al.,
Frontiers in Physiology | www.frontiersin.org

2018a), TRPC5 (Duan et al., 2019), TRPC6 (Bai et al., 2020),
and the yeast TRPY1 (Ahmed et al., 2021) also show phospholipid
or CHS-like densities in this site. Endocannabinoids, such as
anandamide and N-arachidonoyl dopamine, are also thought
to activate TRPV1 by binding to this site (Li et al., 2021).
Thus, the vanilloid binding site is likely an important lipid
binding site in most TRP channels; differences in state-dependent
lipid binding as revealed from cryo-EM structures suggest
distinct effects of lipids in regulating TRP channel structure
and function.

VSLD Binding Site

In many TRP channels, the VSLD, which comprised the S1–S4
helix bundle, forms an inner leaflet ligand binding pocket
(Figure 6). Ligands that act through this site include the
TRPM8 agonists, menthol and icilin (Yin et al., 2018, 2019),
the TRPC6 inhibitor, AM-1473 (Bai et al., 2020), the TRPV3
inhibitor, osthole (Neuberger et al., 2021), and the TRPV6
inhibitor, 2-Aminoethoxydiphenyl borate (2-APB; Singh et al.,
2018). When 2-APB binds to this site in TRPV6, the associated
conformational change at the bottom of S3 and the S4–S5
linker upwardly displaces a nearby lipid in the VSLD binding
site and is associated with closure of the lower gate in the
pore (Singh et al., 2018). A putative activating lipid in the
vanilloid binding site is also displaced upward with 2-APB
binding (Singh et al., 2018). In addition to TRPV6, other
structures that also demonstrate lipid density in the VSLD
binding site are TRPV1 (Gao et al., 2016), TRPV3 (Deng
et al., 2020), and TRPV5 (Hughes et al., 2018a).

PIP2 and Other Lipid Binding Sites

Most TRP channels are regulated by PIP2, a major
phosphoinositide in the plasma membrane inner leaflet. Both
positive and negative regulatory effects of PIP2 have been
reported in TRPV1 and other TRP channels, and there is
evidence to suggest that multiple distinct binding sites account
for these varied effects (Yazici et al., 2021). While
phosphoinositides, such as PI antagonize TRPV1 activation by
competing for vanilloid agonist binding, another site(s) likely
mediates PIP2 activation of TRPV1. Molecular docking and
MD simulations identified a putative PIP2 binding site in
TRPV1, adjacent to the vanilloid binding site, where the
headgroup is interacting with basic residues in the S4-S5 linker
and TRP domain (Poblete et al., 2015; Yazici et al., 2021).
Mutations of these residues significantly right-shift the PIP2
dose–response curve (Poblete et al., 2015). Strikingly, a cryo-EM
structure of TRPV5 in MSP2N2 asolectin nanodiscs with diC8PIP2 shows a PIP2 headgroup bound to approximately the same
inner leaflet site as was predicted for TRPV1, interacting with
basic residues (R302 and R384) in the S4–S5 linker and the
N-linker before the pre-S1 helix (Figures 6, 8A; Hughes et al.,
2018b). The structure demonstrates how PIP2 binding produces
an outward shift of the S4-S5 linker, S6 and the TRP domain
(Figure 8A), which leads to widening of the lower gate and
the selectivity filter. MD simulations also show that PIP2 stably
binds to this site in TRPV6 (Hughes et al., 2018b). Thus, this
10
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site may mediate PIP2 activation of multiple TRP channels in
the vanilloid subfamily including TRPV1, TRPV5, and TRPV6.
Cryo-EM structures of TRPM8 in complex with PIP2 reveal
a distinct inner leaflet PIP2 binding site, where the headgroup
interacts with the pre-S1 domain, TRP domain, S4-S5 linker
and MHR4 (melastatin homology region; Figures 6, 8B; Yin
et al., 2019). Compared to the TRPV5 PIP2 binding site, this
site is located on the opposite side of the VSLD and the TRP
domain (Figure 6). The structure of TRPM8 complexed with
PIP2 and the agonist, icilin, demonstrates allosteric coupling
between these ligands: high occupancy of icilin in the VSLD
inner leaflet site is associated with an upward tilt of the TRP
domain and movement of S4 and S5 that enhances interactions
between PIP2 and key residues such as R850 in S5 and R997 in
the TRP domain (Yin et al., 2019; Figure 8B). It is not known

if this novel site is a PIP2-specific binding site in other TRP
channels; nevertheless, multiple TRP channel structures show
phospholipid or CHS-like densities at this site including TRPM4
(Autzen et al., 2018; Duan et al., 2018b), TRPC3 (Fan et al.,
2018), TRPC4 (Duan et al., 2018a), TRPC5 (Duan et al., 2019),
and TRPA1 (Suo et al., 2020).
In addition to inner leaflet lipid binding sites, multiple lipid
densities are often present at outer leaflet sites in TRP channel
structures (Gao et al., 2016; Autzen et al., 2018; Deng et al.,
2020). The most commonly observed site is located between
the pore helix and outer portion of S6 of the adjacent subunit
(Figure 6), and structures of some TRP channels suggest that
lipid binding at this site is state-dependent. For example, the
structures of TRPV3 in MSP2N2 asolectin nanodiscs show a
phospholipid density at this site that shifts its binding mode

A

B

FIGURE 8 | PIP2 binding sites in TRP channels. (A) TRPV5 with PIP2 (pdb 6dmu) and TRPV5 without PIP2 (pdb 5irx). R302 and R384 are predicted to interact with
the PIP2 headgroup. Binding of PIP2 is associated with outward movement of the S4-S5 linker and S6 away from the pore axis. (B) TRPM8 with PIP2 and icilin (pdb
6nr3) and TRPM8 with low occupancy icilin (pdb 6nr4). K605, R850, and R997 are predicted to interact with the PIP2 headgroup. Binding of the agonist icilin with
high occupancy (not shown in this image) is associated with tilting of the TRP domain and movement of S4 (S4b) and S5, which brings R850 and R997 near the
PIP2 headgroup.
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with channel activation as the pore helix moves downward
opening the selectivity filter (Deng et al., 2020). Structures of
TRPM8 in amphipols show a CHS-like density at this site in
the desensitized conformation that is absent in the closed
conformation, due to a large conformational change in the
outer pore loop and pore helix that occludes this site (Diver
et al., 2019). Structures of TRPM4 (Autzen et al., 2018; Duan
et al., 2018b), TRPC3 (Fan et al., 2018), TRPC4 (Duan et al.,
2018a), TRPC5 (Duan et al., 2019), and TRPC6 (Bai et al.,
2020) also show a phospholipid or CHS-like density at this
site. Multiple TRP channels are positively or negatively regulated
by steroids (Morales-Lazaro and Rosenbaum, 2017), including
pregnenolone sulfate (PS) activation of TRPM3 (Wagner et al.,
2008; Uchida et al., 2016) and testosterone activation of TPRM8
(Asuthkar et al., 2015a,b). Interestingly, TRPM3 activation by
pregnenolone sulfate is only observed with extracellular
application of this anionic neurosteroid, meaning that it is
likely acting through an outer leaflet binding site. The outer
leaflet pore helix/S6 lipid binding site could be the site of
action for PS in TRPM3, although this remains to be tested
and there is no available structure for this channel.

hypothesis is difficult to test and has seldom been demonstrated.
However, there are a few examples among TRP channels and
pLGICs that suggest interactions between lipids and ligands.
These include PI inhibition of capsaicin activation of TRPV1
(Yazici et al., 2021), PS inhibition of ivermectin binding in
GluCl (Hibbs and Gouaux, 2011), or cholesterol inhibition
of neurosteroid potentiation of the GABAAR (Sooksawate and
Simmonds, 2001b). In the latter case, epi-cholesterol (the
3-hydroxy diastereomer of cholesterol) does not have the
same effect as cholesterol, arguing for a direct/specific
interaction. Although it is still difficult to rule out an allosteric
mechanism of cholesterol inhibition of neurosteroid effect,
the fact that cholesterol and neurosteroids compete for common
sites in pLGICs (Budelier et al., 2019; Lee, 2021) supports
a competitive mechanism. There are also differences in general
anesthetic potency that may be a consequence of changes in
lipid environment. For example, diet-induced depletion of
rat brain ω-3 and ω-6 fatty acid content significantly increases
sensitivity to volatile anesthetics (Evers et al., 1986). Moreover,
volatile anesthetics are less potent in infants, and more potent
in neonates, the elderly and pregnant women. While there
could be a multitude of factors that contribute to these
differences (Moody et al., 2021), it is plausible that changes
in neuronal lipid membrane content with age or different
physiologic states contributes to anesthetic sensitivity by
modulating GABAAR function. Lipids may alter anesthetic
sensitivity through competitive or non-competitive mechanisms.
As our molecular and cellular understanding of lipid regulation
of ion channels advance, it may be feasible to test these
ideas directly.

DISCUSSION
Two interesting observations arise from examining bound lipids
in high-resolution structures of pLGICs and TRP channels.
First, many of these lipid binding sites are known sites for
exogenous ligands/drugs. Notable examples are the binding
site for anesthetics in the outer leaflet intersubunit pocket in
the GABAAR or the vanilloid binding site in TRPV1. Second,
the sites of lipid binding, even those which are not shared
by other ligands, are often conserved among different pLGICs
or TRP channels. While it remains unclear in most cases
whether lipid occupancy of these sites is functionally important,
the above observations suggest that these sites are likely allosteric
hotspots in the transmembrane domain of these proteins
(Reynolds et al., 2011), and promising targets for structurebased drug design. Indeed, structure-based virtual screening
of the econazole binding pocket in TRPV5, which is equivalent
to the vanilloid binding site in TRPV1, yielded several high
affinity and specific inhibitors of TRPV5 (Hughes et al., 2019).
The binding pocket of a lipid may be overlapping but
non-identical to that of a drug at the same site such that
unique lipid-protein interactions may contribute to its binding
and effect. For example, PI interacts with residues in the
vanilloid binding pocket that are not shared with RTX or
capsaicin (Gao et al., 2016), and mutation of these residues
alter PI inhibition and vanilloid agonist sensitivity in TRPV1
(Yazici et al., 2021). As drug design targeting the lipid-protein
interface gains interest (Payandeh and Volgraf, 2021),
understanding the determinants of lipid binding and regulation
of ion channels may facilitate this effort.
The finding that many hydrophobic drugs/ligands share
binding sites with lipids also raises the hypothesis that the
cellular lipid environment influences the potency of these
drugs through competitive interactions with lipids. Such a
Frontiers in Physiology | www.frontiersin.org

KNOWLEDGE GAPS AND FUTURE
DEVELOPMENTS
The availability of cryo-EM structures of ion channels with
bound lipids is a critical starting point to understanding
structural mechanisms of lipid regulation. For most of these
structures, it is unknown whether these sites are selective for
certain lipids and whether lipids regulate channel function by
binding to these sites. With structure determination accelerating,
two major knowledge gaps need to be addressed concurrently:
(1) understanding the exact effects of lipids on ion channel
function and (2) determining lipid binding affinities at specific
sites in different conformational states. Such understanding
taken together will be necessary to answer the essential question
of whether certain lipids regulate ion channel function through
a specific site(s) or through indirect effects on lipid bilayer
properties. We highlight several approaches and suggest new
developments to these techniques to address the above
knowledge gaps.

Functional Measurements of Lipid
Regulation

Lipid regulation of ion channel function is best determined
in model membranes where lipid composition can be precisely
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controlled. The necessity of reconstituting biochemical
quantities of pure, functional protein has made such
experiments challenging and mostly limited to prokaryotic
ion channels. However, advances in large-scale expression
of mammalian membrane proteins (Goehring et al., 2014)
and solubilization/reconstitution in superior detergents or
nanodisc scaffolds (Chae et al., 2012; Dorr et al., 2014;
Winterstein et al., 2018; Yu et al., 2021) should enable more
functional studies of mammalian ion channels in model
membranes. Ion channel function can be assessed in planar
lipid bilayers, giant liposomes by excised patch-clamp, or
small unilamellar liposomes with tracer flux measurements.
While the former two permit measurements of single channel
currents, the latter provides the most versatile system for
reconstitution in a wide range of lipid environments including
asymmetric bilayers (Doktorova et al., 2018). Recently,
measurements of transporter function in stably asymmetric
liposomes were reported (Markones et al., 2020). It is
conceivable that established methods to manipulate
phospholipid content in the outer leaflet of liposomes
(Markones et al., 2018, 2020) could be interfaced with ion
channel flux assays in proteoliposomes. Activating ligandgated ion channels from the extra-liposomal space would
guarantee that only the activity of channels of one orientation
would be measured, ensuring the relevance of the asymmetric
bilayer. Such an approach could be used to mimic nativelike asymmetric lipid environments. More interestingly, it
could also be used to definitively determine if a specific
lipid regulates ion channel function from the inner or outer
leaflet, clarifying whether an inner or outer leaflet site
mediates the effect. Asymmetric planar lipid bilayers or the
recently developed contact bubble bilayer were used to
demonstrate that anionic phospholipids activate the
prokaryotic potassium channel, KcsA, and viral potassium
channels from the inner leaflet (Iwamoto and Oiki, 2013,
2015; Winterstein et al., 2021). However, unlike liposomes
in which methods such as zeta potential measurements are
available to verify generation and stability of an asymmetric
bilayer (Markones et al., 2018), no such verification procedure
is routinely applied for asymmetric planar bilayers or contact
bubble bilayers such that one is less certain if inter-leaflet
mixing or protein-induced scrambling of lipids takes place
in these systems (Montal and Mueller, 1972).
Functional studies of ligand-gated ion channels also require
the capability to examine gating kinetics, including processes
such as rapid activation in response to agonist and slow
desensitization in the continued presence of agonist. This
can be achieved with a stopped-flow fluorometric ion flux
assay (Posson et al., 2018), which measures the rate of
fluorescence quenching of a fluorophore as a quenching ion
(usually thallium) enters the liposomes through ion channels.
This technique has been successfully applied to proton-gated
(Rusinova et al., 2014), calcium-gated (Posson et al., 2015),
cyclic nucleotide-gated (Schmidpeter et al., 2020), and
pentameric ligand-gated ion channels (Menny et al., 2017;
Tong et al., 2019). We anticipate that the stopped-flow ion
flux assay, together with innovative methods to make asymmetric
Frontiers in Physiology | www.frontiersin.org

proteoliposomes, will provide novel insights into the mechanism
of lipid regulation of ion channels.

Measurements of Lipid Binding

Assessment of lipid binding sites and affinities, especially
state-dependent binding, is a challenging but critical step to
understand lipid regulation of ion channels through a direct
binding mechanism. Crystallography and cryo-EM undoubtedly
remain powerful approaches to identify lipid binding sites
and protein conformational changes associated with bound
lipids. Future studies will likely seek to obtain structures of
a single ion channel reconstituted with different lipids in the
same nanodisc scaffold; this may be a useful approach to
systematically examine the specificity and structural effects
of lipid binding. The presence and absence of lipids in different
conformational states from such structures suggests statedependent lipid binding. However, the absence of a resolved
lipid density does not rule out occupancy of a specific lipid
at a given site. An example of this is the case of neurosteroid
binding to the GABAAR. While crystal structures only show
neurosteroid binding to an inner leaflet intersubunit site
(Laverty et al., 2017; Miller et al., 2017; Chen et al., 2018),
photolabeling studies also indicate neurosteroid binding to
outer leaflet M1/M4 and M3/M4 intrasubunit sites (Chen
et al., 2019; Sugasawa et al., 2019, 2020). The absence of
neurosteroids at these sites in the structures could be because
the neurosteroid is highly flexible in these sites (multiple
binding modes), or that binding favors a conformation not
captured in the structures. It is also possible that the process
of membrane protein crystallization or cryogenic freezing,
or the use of detergents and nanodisc scaffolds alters the
interaction of lipids with membrane proteins. Moreover, lipid
densities from cryo-EM and crystallography studies may not
provide the resolution to definitively distinguish one lipid
species from another. For these reasons, photo-affinity labeling,
combined with residue-level identification of labeled sites by
mass spectrometry, offers a complementary approach for
identifying lipid binding sites, and has been utilized to identify
cholesterol and neurosteroid binding sites in membrane proteins
(Budelier et al., 2017a,b; Cheng et al., 2018; Krishnan et al.,
2021). A recent study also showed that photo-affinity labeling
can be used to identify binding sites for the polyunsaturated
fatty acid, DHA, in a pLGIC, and to assess state-dependent
binding of DHA at these sites (Dietzen et al., 2021). The
same strategy should be feasible for other lipids, such as
sphingolipids (Dadsena et al., 2019), phospholipids and
lysophospholipids (Xia and Peng, 2013; Peng et al., 2014),
endocannabinoids (Dixon et al., 2012), or fatty acid metabolites
for residue-level identification of binding sites. Developing
new reagents with optimal photochemistry, especially the use
of trifluoromethylphenyl diazirine (TPD) photoreactive groups,
may be essential for this effort (Cheng et al., 2019; Dietzen
et al., 2021; Krishnan et al., 2021). Once a site(s) is identified,
competition photolabeling experiments with any lipid or ligand
can be used to determine relative binding affinities at individual
sites as well as state-dependent changes in binding affinity,
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as has been extensively applied for anesthetic binding sites
in the GABAAR (Li et al., 2010; Chiara et al., 2013; Jayakar
et al., 2014, 2019).
Other experimental methods to examine lipid binding affinities
in ion channels include tryptophan fluorescence quenching by
brominated lipids (Powl et al., 2003; Carney et al., 2007; Marius
et al., 2008), a soluble lipid-binding assay using a fluorescently
tagged channel and lipid with fluorescence or bioluminescence
resonance energy transfer (FRET/BRET; Cabanos et al., 2017;
Robinson et al., 2019), and native mass spectrometry (Laganowsky
et al., 2013, 2014). These are useful methods to measure direct
lipid binding and relative affinities and should also permit
assessment of state-dependent lipid binding (Powl et al., 2005;
Tong et al., 2019). However, they suffer from relatively low
structural resolution, reducing the certainty that lipid binding
is measured from a single site. While BRET or FRET Ro distances
(distance of 50% energy transfer) range from 2 to 10 nm
(Clegg, 1995; Weihs et al., 2020), the Ro for quenching of
brominated lipids is ~8 Å providing the best resolution.
Unfortunately, most ion channels have multiple tryptophans in
the TMD, such that binding to a single site cannot be interrogated
using the native channel. It may be possible to examine binding
to single sites with brominated lipids by removing native
tryptophans (Chen et al., 2010) or site-specific introduction of
a fluorescent, unnatural amino acid such as ANAP (Puljung, 2021).
Molecular dynamics (MD) simulations, with unparalleled
spatiotemporal resolution, have also been leveraged to characterize
binding of lipids to a wide range of membrane proteins including
ion channels (Kasimova et al., 2014; Tian et al., 2019; Buyan
et al., 2020; Dietzen et al., 2021; Kapoor et al., 2021). A major
hurdle is the mismatch between the timescales accessible to
MD simulations and the rates of native lipid diffusion, limiting
sampling of binding sites by lipid species. Efforts to reduce this
mismatch are ongoing including development of hyper-specialized
computational hardware and exploitation of graphics processing
units (Salomon-Ferrer et al., 2013; Eastman et al., 2017; Kutzner
et al., 2019; Phillips et al., 2020). Despite these advances,
milliseconds is still the longest timescale available to all-atom
MD simulations even with hyper-specialized hardware (Carnevale
et al., 2021), which may not be sufficient to properly sample
all protein-lipid interactions. Therefore, the use of dimensionreduced systems has become popular to study lipid binding
(Ohkubo et al., 2012; Panahi and Feig, 2013; Souza et al., 2021).
Dimension-reduced systems (i.e., coarse-grained, implicit solvent/
membrane, united atom approach) improve protein-lipid sampling
by reducing the number of calculations needed per time, allowing
the simulation to reach longer timescales. The trade-off is that
significant atomic-level detail is lost. In some cases (i.e., coarsegrained systems), this can be rectified by backmapping, or reverse
coarse-graining, to obtain all-atom systems (Wassenaar et al.,
2014). Such a strategy has been applied to improve protein-lipid
sampling and achieve atomistic detail in studying lipid interactions
with a pLGIC (Sridhar et al., 2021).
Enhanced sampling techniques may also be useful to
improve modeling of the equilibrium ensemble of membrane
protein systems (Bernardi et al., 2015; Yang et al., 2019).
These techniques exploit the unique ability of simulation to
Frontiers in Physiology | www.frontiersin.org

selectively modify the energetic landscape of the system (Mori
et al., 2013; Miao et al., 2020), and preferentially sample the
microstates of the statistical ensemble that are desired
(Zimmerman and Bowman, 2015; Zuckerman and Chong,
2017). These novel techniques have yet to be extensively
applied to lipid binding in membrane proteins. However, a
recent study showed that information obtained from enhanced
sampling can be reweighted to determine the energetics and
kinetics of protein-lipid interactions (Bhattarai et al., 2020).
Lastly, classic free energy calculations are being adapted to
study lipid binding to membrane proteins. Lipid binding sites
present a unique challenge in free energy calculations in that
they are generally superficial, and it is difficult to distinguish
bound lipid from unbound lipid as it is both ligand and
solvent. Changing the definition of a bound ligand/lipid
(streamlined alchemical free energy perturbation, SAFEP) has
allowed more accurate quantification of binding free energies
and description of the non-ideality of cholesterol-GPCR
interactions (Salari et al., 2018). This new approach promises
to shed light on many protein-lipid interactions by calculating
free energies of lipid binding to specific sites. Ideally, comparison
of such free energy calculations with experimentally determined
binding affinities would provide the most convincing application
of these methods.

CONCLUSION
High-resolution structures of ion channels, especially those
embedded in lipid nanodiscs, show multiple lipid-drug binding
sites in pLGIC and TRP channel families. While these sites are
generally conserved among multiple members of each family,
they are also the sites of action of some highly specific and
potent ligands such as ivermectin in GluCl, capsaicin in TRPV1,
and GNE551 in TRPA1. Thus, drug discovery efforts targeting
these lipid binding sites in different channel subtypes may yield
specific new modulators/inhibitors as was the case for TRPV5
(Hughes et al., 2019). Current understanding of how lipids
regulate ion channel structure and function through these sites
is far from complete and does not enable even qualitative
predictions of lipid interactions with these proteins. Future research
should focus on understanding the specificity and determinants
of lipid binding to these sites in different functional states.
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